Merdad Parsey - Jun 10, 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Medical Officer
Signature
/s/ Edward S. Son by Power of Attorney for Merdad Parsey
Stock symbol
GILD
Transactions as of
Jun 10, 2022
Transactions value $
-$29,459
Form type
4
Date filed
6/13/2022, 07:53 PM
Previous filing
Mar 14, 2022
Next filing
Sep 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +1.04K +2.5% 42.7K Jun 10, 2022 Direct F1
transaction GILD Common Stock Tax liability -$29.5K -485 -1.14% $60.74 42.2K Jun 10, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -1.04K -1.99% 51.3K Jun 10, 2022 Common Stock 1.04K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.